Justin Zelin
Stock Analyst at BTIG
(3.19)
# 2,435
Out of 4,579 analysts
331
Total ratings
35.6%
Success rate
2.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintained: Buy | $9 | $6.99 | +28.76% | 6 | Feb 2, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | $100 | $15.57 | +542.26% | 8 | Jan 22, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.78 | +405.62% | 5 | Jan 6, 2026 | |
| SNDX Syndax Pharmaceuticals | Maintained: Buy | $56 | $20.52 | +172.90% | 26 | Jan 2, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $45 | $30.16 | +49.20% | 2 | Jan 2, 2026 | |
| KURA Kura Oncology | Maintained: Hold | n/a | $10.15 | - | 20 | Dec 9, 2025 | |
| TCRX TScan Therapeutics | Reiterated: Hold | n/a | $0.7683 | - | 10 | Dec 9, 2025 | |
| JSPR Jasper Therapeutics | Maintained: Buy | $7 | $0.6943 | +908.21% | 14 | Dec 2, 2025 | |
| AAPG Ascentage Pharma Group International | Maintained: Buy | $50 | $18.89 | +164.69% | 2 | Dec 2, 2025 | |
| BCAB BioAtla | Maintained: Buy | $500 | $3.40 | +14,605.88% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.08 | +228.95% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $36.77 | +68.62% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $34.87 | +258.47% | 36 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.77 | +351.47% | 2 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $52.74 | -14.67% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $19.27 | +372.24% | 38 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $33.77 | n/a | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0045 | n/a | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $8.06 | n/a | 21 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.54 | n/a | 10 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $7.25 | n/a | 15 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $0.56 | n/a | 22 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1288 | n/a | 8 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9765 | n/a | 14 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.3619 | n/a | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.48 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0004 | n/a | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $3 | $6.13 | n/a | 4 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $351.82 | n/a | 2 | Nov 11, 2020 |
ImmunityBio
Feb 2, 2026
Maintained: Buy
Price Target: $9
Current: $6.99
Upside: +28.76%
Janux Therapeutics
Jan 22, 2026
Maintained: Buy
Price Target: $100
Current: $15.57
Upside: +542.26%
NovaBridge Biosciences
Jan 6, 2026
Reiterated: Buy
Price Target: $9
Current: $1.78
Upside: +405.62%
Syndax Pharmaceuticals
Jan 2, 2026
Maintained: Buy
Price Target: $56
Current: $20.52
Upside: +172.90%
ArriVent BioPharma
Jan 2, 2026
Maintained: Buy
Price Target: $45
Current: $30.16
Upside: +49.20%
Kura Oncology
Dec 9, 2025
Maintained: Hold
Price Target: n/a
Current: $10.15
Upside: -
TScan Therapeutics
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.7683
Upside: -
Jasper Therapeutics
Dec 2, 2025
Maintained: Buy
Price Target: $7
Current: $0.6943
Upside: +908.21%
Ascentage Pharma Group International
Dec 2, 2025
Maintained: Buy
Price Target: $50
Current: $18.89
Upside: +164.69%
BioAtla
Nov 14, 2025
Maintained: Buy
Price Target: $500
Current: $3.40
Upside: +14,605.88%
Nov 4, 2025
Reiterated: Buy
Price Target: $20
Current: $6.08
Upside: +228.95%
Nov 4, 2025
Reiterated: Buy
Price Target: $62
Current: $36.77
Upside: +68.62%
Oct 30, 2025
Reiterated: Buy
Price Target: $125
Current: $34.87
Upside: +258.47%
Sep 17, 2025
Reiterated: Buy
Price Target: $8
Current: $1.77
Upside: +351.47%
Aug 14, 2025
Reiterated: Buy
Price Target: $45
Current: $52.74
Upside: -14.67%
Aug 11, 2025
Reiterated: Buy
Price Target: $91
Current: $19.27
Upside: +372.24%
Mar 11, 2025
Reiterated: Buy
Price Target: $91
Current: $33.77
Upside: n/a
Jan 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0045
Upside: n/a
Sep 10, 2024
Maintained: Buy
Price Target: $6
Current: $8.06
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $5
Current: $1.54
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $30
Current: $7.25
Upside: n/a
Mar 12, 2024
Maintained: Buy
Price Target: $8
Current: $0.56
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.1288
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.9765
Upside: n/a
Dec 4, 2020
Initiated Coverage: Buy
Price Target: $4
Current: $0.3619
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $4
Current: $1.48
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $28
Current: $0.0004
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $2 → $3
Current: $6.13
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $100
Current: $351.82
Upside: n/a